531762-BOM

Unjha Formulations Ltd.

BSE: 531762

Sector: Healthcare

Industry Group: Pharmaceuticals & Biotechnology

Industry: Pharmaceuticals

24.28+0.9 (+3.81%)

10 Jul, 12:00 AM

Overview

Analysis Statements Technicals Forecast Peers Resources News

Stock Scores

Quality Score

Score not available

Value Score

Score not available

Price Momentum Score

Score not available

QVM Score

Score not available

Key Metrics

Market Cap

10.88

P/E (TTM)

15.44

P/B

2.83

P/S (TTM)

0.70

EV/EBITDA

9.82

CAPE (5Y)

ROE (TTM)

20.19

ROCE (TTM)

ROA (TTM)

14.00

Avg 3Y ROE

14.93

Earnings 3Y CAGR

35.62

Sales 3Y CAGR

5.82

Sales 5Y CAGR

Debt/Equity

0.00

Consensus TP

Strong Buy %

Promoter Holding

36.92

Pledged %

0.00

Stock Analysis

Fundamental analysis overview of Unjha Formulations Ltd. covering key investment insights, growth drivers, risk factors, and potential red flags.

Views

Red Flags

Positive

Stock is reasonably valued and PE TTM is at a discount to industry median

PE TTM of 15.44 indicates that the stock is reasonably valued on a standalone basis. Discount to industry median P/E is decent at -50.24%

What is P/E Ratio?

Median: 31.03

Value 15.44

-215.443203.67

High ROE

The company reported strong ROE of 20.19% for 12-month ended 31 Mar 2026

What is ROE (FY)?

Strong EPS growth and above median growth of industry

The company delivered strong EPS growth of 72.82% for 12-month ended 31 Mar 2026 and the growth was 64.7 percentage points higher than median growth of industry

What is EPS growth (1Y)?

Low Debt to Equity

The company has low Debt to Equity of 0.0 as on 31 Mar 2026

What is Debt to Equity?

Consistently pays dividend

The company has not missed dividend payments once in the last 4 financial years

What is Dividend streak?

Company is net cash

The company is net cash i.e., cash and cash equivalents exceed total debt indicating a healthy balance sheet

What is Net Debt ?

Negative

Low dividend yield

The company has a low dividend yield of 0.0%

What is Dividend yield?

Neutral

Moderate revenue growth and in line with median growth of industry

The company delivered moderate revenue growth of 12.43% for 12-month ended 31 Mar 2026 and the growth was 1.19 percentage points higher than median growth of industry

What is Sales growth (1Y)?

Median: 11.24

Value 12.43

-82.35114662

Financial Snapshot

See detailed analysis

Multi-year trends for Unjha Formulations Ltd. covering revenue, net profit, ROE, and EBITDA for a quick view of financial health over time.

Net Revenue FY

Profit After Tax FY

ROE FY

EBITDA FY

Unjha Formulations Ltd. Shareholding Pattern

Quarterly breakdown of Unjha Formulations Ltd. ownership including promoter, FII, DII, mutual fund, and public holdings as disclosed to NSE/BSE.

	Mar 2020	Jun 2020	Sep 2020	Dec 2020	Mar 2021	Jun 2021	Sep 2021	Dec 2021	Mar 2022	Jun 2022	Sep 2022	Dec 2022	Mar 2023	Jun 2023	Sep 2023	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025	Mar 2026
Total Promoter	36.92	36.92	36.92	36.92	36.92	36.92	36.92	36.92	36.92	36.92	36.92	36.92	36.92	36.92	36.92	36.92	36.92	36.92	36.92	36.92	36.92	36.92	36.92	36.92	36.92
Indian Promoter	36.92	36.92	36.92	36.92	36.92	36.92	36.92	36.92	36.92	36.92	36.92	36.92	36.92	36.92	36.92	36.92	36.92	36.92	36.92	36.92	36.92	36.92	36.92	36.92	36.92
Foreign Promoter	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Institutions	0.02	0.02	-	-	-	-	-	-	-	-	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Mutual Funds / UTI	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
FI/Bank/Insurance	0.02	0.02	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Govt	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
FII	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Other Institutions	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Non-Institution	63.05	63.05	63.08	63.08	63.08	63.08	63.08	63.08	63.08	63.08	63.08	63.08	63.07	63.08	63.08	63.08	63.08	63.08	63.08	63.08	63.08	63.08	63.08	63.08	63.08
Bodies Corporate	-	-	-	-	-	-	-	-	-	-	0.62	0.40	0.42	0.42	0.68	1.15	0.96	0.44	0.43	0.61	0.58	1.06	1.20	1.11	0.94
Others (incl. Retail) No. of shareholders	63.05 3,556	63.05 3,554	63.08 3,570	63.08 3,561	63.08 3,627	63.08 4,269	63.08 4,106	63.08 4,130	63.08 4,191	63.08 4,146	62.46 4,104	62.68 3,998	62.65 3,973	62.66 3,943	62.40 3,972	61.93 3,991	62.12 3,913	62.64 3,966	62.65 3,950	62.47 4,187	62.50 4,252	62.02 4,187	61.88 4,259	61.97 4,230	62.14 4,214

Holdings and Presence

Indices and prominent investors with a stake in this stock.

Index Presence

Unjha Formulations Ltd. is not part of any tracked index.

Prominent Investor Holdings

Dheeraj Kumar Lohia and Associates

Dec 2023

1.15%

₹ 0 Cr

Bulk, Block and Insider Trades

Recent bulk deals, block deals, and insider trading activity in Unjha Formulations Ltd. shares as reported to NSE and BSE.

No bulk, block or insider trade data available.

No corporate action data available.

Company Profile

Overview of Unjha Formulations Ltd. covering business description, industry classification, key management, financial ratios, and listed exchange details.

Unjha Formulations Limited is an India-based company, which is engaged in manufacturing and exporting of isabgol (psyllium) ayurvedic products. The Company is engaged in service to the isabgol (psyllium) ayurvedic formulation profession. It also manufactures all kinds of small volume ayurvedic isabg...

Key personnel

Ms. Khushboo N. Patel

Compliance Officer, Company Secretary

Ms. Esha Mayank PatelD

Executive Director

Ms. Krutiben M. PatelD

Whole time Director

Shri. Jitendrakumar Parshottamdas LimbachiyaD

Additional Independent Director

Shri. Hasmukh C. ChavdaD

Non-Executive Independent Director

Incorporated on

02 Sep 1994

Last Annual

31 Mar 2026

Last Interim

31 Mar 2026

No. of Employees

IPO date

07 Mar 1996

Free Float

25,39,626

Website

https://www.unjhaformulations.com/

Phone no.

+912767282395

Address

KHALI CHAR RASTA,STATE HIGHWAY TAL-SIDHPUR, PATAN KHALI, PATAN, , 384151, India

Frequently Asked Questions

What is the current share price of Unjha Formulations Ltd.?

The current share price of Unjha Formulations Ltd. is ₹ 24.28 as of 10 Jul 2026.

What is the market capitalisation of Unjha Formulations Ltd.?

The market capitalisation of Unjha Formulations Ltd. stands at ₹ 10.88 Cr.

What is the PE ratio of Unjha Formulations Ltd.?

The Price-to-Earnings (PE) ratio of Unjha Formulations Ltd. is 15.44 as of the latest trailing twelve months data.

What is the ROE and ROCE of Unjha Formulations Ltd.?

Unjha Formulations Ltd. has a Return on Equity (ROE) of 20.19% and a Return on Capital Employed (ROCE) of - as per the latest financial reports.

What is the 52-week high and low of Unjha Formulations Ltd.?

The 52-week high of Unjha Formulations Ltd. is - and the 52-week low is -.

What is the dividend yield of Unjha Formulations Ltd.?

The dividend yield of Unjha Formulations Ltd. is 0.00% based on the current market price.

What is the FII and DII holding in Unjha Formulations Ltd.?

Foreign Institutional Investors (FII) hold 0.00%, Domestic Institutional Investors (DII) hold 0.00% and retail/public investors hold 62.14% of Unjha Formulations Ltd. shares.

What sector does Unjha Formulations Ltd. belong to?

Unjha Formulations Ltd. operates in the Healthcare sector.

What is the beta of Unjha Formulations Ltd.?

The beta of Unjha Formulations Ltd. is 0.66, indicating its price volatility relative to the broader market. Over the past 1 year, Unjha Formulations Ltd. has delivered an absolute return of 5.80%.

What is the RSI of Unjha Formulations Ltd.?

The 14-day Relative Strength Index (RSI) of Unjha Formulations Ltd. is 70.52, placing it in the overbought zone. An RSI above 70 is considered overbought and below 30 is considered oversold.

Unjha Formulations Ltd.

Stock Scores

Key Metrics

Share Price

Stock Analysis

Financial Snapshot

Unjha Formulations Ltd. Shareholding Pattern

Holdings and Presence

Bulk, Block and Insider Trades

Company Profile

Frequently Asked Questions

Stock Analysis

Holdings and Presence

Company Profile